Statement Of Financial Position [Abstract]

ERYTECH Pharma S.A. - Filing #880081

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
18 960 EUR
20 862 EUR
25 632 EUR
Intangible assets other than goodwill
15,000 EUR
589,000 EUR
603,000 EUR
Cash and cash equivalents
33 699 EUR
44 446 EUR
73 173 EUR
Assets
66 768 EUR
80 402 EUR
118 545 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
3 102 EUR
2 006 EUR
1 794 EUR
Share premium
97 618 EUR
120 705 EUR
281 688 EUR
Other reserves
25 293 EUR
24 616 EUR
136 607 EUR
Equity
25 293 EUR
22 845 EUR
53 797 EUR
97 618 EUR
1 215 EUR
3 102 EUR
2 006 EUR
1 744 EUR
24 616 EUR
120 705 EUR
26 539 EUR
73 300 EUR
136 607 EUR
1 344 EUR
281 688 EUR
85 560 EUR
1 794 EUR
62 659 EUR
99 524 EUR
188,000 EUR
281 744 EUR
145 602 EUR
1 794 EUR
38 224 EUR
Liabilities [abstract]
Deferred tax liabilities
EUR
EUR
EUR
Equity and liabilities
66 768 EUR
80 402 EUR
118 545 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.